Intratumoral injections of compound NSC405020 [3,4-dichloro-N-(1-methylbutyl)benzamide] (Figure 4), an MT1-MMP HPX domain binder, reduced MCF7-β3/MT tumor xenograft size significantly [122]. The gene discussed is MMP14; the disease is neoplasm.